ACEPODIA

Class [5]
Pharmaceutical Products

Biological preparations for medical or therapeutic purposes; biological tissue cultures for medical purposes; medicines for human purposes; drugs for medical purposes; pharmaceuticals; cells for clinical, medical, veterinary, or therapeutic purposes or use; cell-derived preparations, namely, natural killer cell, gamma delta T cell, or other immune cell-derived preparations, for clinical, medical, veterinary, or therapeutic purposes; therapeutic products derived from cells or cell-derived preparations, namely, natural killer cells, gamma delta T cell, or other immune cell, for clinical, medical, veterinary, or therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, or therapeutic purposes or use; kits comprised of cell-derived preparations, namely, natural killer cell, gamma delta T cell, or other immune cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, or therapeutic purposes or use; gene therapy products, namely, genetically engineered cells for medical or clinical purposes or use; pharmaceutical preparations, pharmaceutical products, therapeutic agents, or drugs, for targeting tissues based on select tissue markers and ligands, or for the purpose of binding ligands using engineered proteins and receptors; pharmaceuticals, namely, pharmaceutical preparations, pharmaceutical products, therapeutic agents, or drugs, for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and other diseases or disorders, and in cellular transplants; biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic peptide, therapeutic proteins, and therapeutic nucleic acids for human use for the treatment and prevention of cancer, tumors, autoimmune disease, a neuronal disease, a hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; pharmaceutical preparations or pharmaceutical products, namely, cell media for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers; pharmaceutical preparations, biological preparations, or therapeutic agents to modulate cell function or cell fate; reagents for research, drug discovery and development, pre-clinical, clinical, and medical use; biological preparations or therapeutic agents used for medical cell therapy, adoptive immunotherapy, or other immunotherapy; therapeutic cell preparation based on NK cells (natural killer cells), gamma delta T cell, other immune cell, or other cell for the treatment of cancer, tumors, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, auto-immune diseases, and inflammatory and immune disorders Bio-engineered component for a therapeutic material, namely, cell lines based on NK cells (natural killer cells), gamma delta T cell, or other immune cell used for medical or clinical use used for immunotherapy.